It has been reported that dual inhibition of CDK4/6 inhibitor and gemcitabine enhanced the antitumor effect in a xenograft model of lung cancer [22] and CDK4/6 inhibition also sensitized neuroblastoma cells to doxorubicin-induced apoptosis [23]. The gene discussed is CDK4; the disease is lung cancer.